Rocio Acedo-Diaz

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study.

Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study.

Journal: Future oncology (London, England)
Published: September 12, 2024

Systematic review on the use of anticholinergic scales in elderly chronic patients.

Systematic review on the use of anticholinergic scales in elderly chronic patients.

Journal: Research in social & administrative pharmacy : RSAP
Published: April 08, 2024

Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population.

Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: January 24, 2024

Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer.

Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer.

Journal: International journal of clinical pharmacy
Published: July 17, 2023

Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma.

Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 13, 2023

Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss.

Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss.

Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: April 11, 2022

Tagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm.

Tagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm.

Journal: Leukemia & lymphoma
Published: February 24, 2022

Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population.

Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: September 24, 2021

Prevalence of PIMDINAC criteria and associated factors in elderly HIV patients.

Prevalence of PIMDINAC criteria and associated factors in elderly HIV patients.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: October 07, 2020

Real world study of pertuzumab-trastuzumabchemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer.

Real world study of pertuzumab-trastuzumabchemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 27, 2020

Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis.

Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis.

Journal: Journal of clinical pharmacy and therapeutics
Published: January 08, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026